Valuation: Giant Biogene Holding Co., Ltd.

Capitalization 4.63TCr 4.92TCr 631.88Cr 619.49Cr 580.83Cr 519.74Cr 910.7Cr 55TCr 1.03TCr 7.13TCr 2.64TCr 22TCr 2.37TCr 2.32TCr 1LCr P/E ratio 2024 *
23.2x
P/E ratio 2025 * 18.2x
Enterprise value 4.21TCr 4.47TCr 574.7Cr 563.44Cr 528.28Cr 472.71Cr 828.29Cr 50TCr 934Cr 6.48TCr 2.4TCr 20TCr 2.16TCr 2.11TCr 91TCr EV / Sales 2024 *
8.24x
EV / Sales 2025 * 6.05x
Free-Float
42.68%
Yield 2024 *
1.31%
Yield 2025 * 1.66%
More valuation ratios * Estimated data
Dynamic Chart
1 day+6.05%
1 week+10.71%
Current month+3.61%
1 month+0.19%
3 months-1.05%
6 months+27.81%
Current year+3.61%
More quotes
1 week
45.20
Extreme 45.2
52.05
1 month
45.20
Extreme 45.2
52.90
Current year
45.20
Extreme 45.2
52.05
1 year
28.75
Extreme 28.75
58.00
3 years
24.30
Extreme 24.3
58.80
5 years
24.30
Extreme 24.3
58.80
10 years
24.30
Extreme 24.3
58.80
More quotes
Director TitleAgeSince
Chief Executive Officer 58 21/04/2022
Director of Finance/CFO 38 21/04/2022
Corporate Secretary 29 01/10/2018
Manager TitleAgeSince
Chairman 58 21/04/2022
Director/Board Member 54 30/11/2021
Director/Board Member 66 21/04/2022
More insiders
Add to a list
Change 5d. change 1-year change 3-years change Capi. ($)
+6.05%+10.71%+43.81% - 631.88Cr
+0.18%-1.10%+5.47%+0.35%37TCr
-0.62%+0.19%+18.04%+14.45%14TCr
+0.86%-0.50%+7.65%+5.52%7.12TCr
-3.48%-1.00%-7.99%+0.13%6.65TCr
+0.58%-0.66%-2.51% - 4.02TCr
-0.89%-1.54%-6.85%+37.84%2.88TCr
+2.11%+1.94%-44.37%-77.57%2.69TCr
+0.45%-1.39%+10.74%+4.96%1.79TCr
-1.60%-1.16%+0.57%+24.13%1.37TCr
Average +0.14%+0.78%+2.46%+1.23% 7.82TCr
Weighted average by Cap. -0.22%-0.17%+4.48%+2.62%
See all sector performances

Financials

2024 *2025 *
Net sales 511.57Cr 543.25Cr 70Cr 68Cr 64Cr 57Cr 100.56Cr 6.05TCr 113.39Cr 787.24Cr 291.95Cr 2.48TCr 261.93Cr 256.28Cr 11TCr 670.8Cr 712.34Cr 91Cr 90Cr 84Cr 75Cr 131.86Cr 7.93TCr 148.69Cr 1.03TCr 382.82Cr 3.25TCr 343.45Cr 336.05Cr 14TCr
Net income 197.42Cr 209.65Cr 27Cr 26Cr 25Cr 22Cr 39Cr 2.33TCr 44Cr 303.81Cr 112.67Cr 955.62Cr 101.08Cr 99Cr 4.25TCr 251.98Cr 267.59Cr 34Cr 34Cr 32Cr 28Cr 50Cr 2.98TCr 56Cr 387.77Cr 143.8Cr 1.22TCr 129.02Cr 126.24Cr 5.42TCr
Net Debt -419.23Cr -445.19Cr -57Cr -56Cr -53Cr -47Cr -82Cr -4.96TCr -93Cr -645.14Cr -239.25Cr -2.03TCr -214.65Cr -210.02Cr -9.01TCr -576.15Cr -611.83Cr -79Cr -77Cr -72Cr -65Cr -113.25Cr -6.81TCr -127.71Cr -886.62Cr -328.8Cr -2.79TCr -294.99Cr -288.63Cr -12TCr
More financial data * Estimated data
Logo Giant Biogene Holding Co., Ltd.
Giant Biogene Holding Co Ltd is a China-based investment holding company. The Company is principally engaged the research, development, manufacture and sale of bioactive material-based beauty and health products through its subsidiaries. The Company's main products include functional skincare products and medical dressings, and they are produced with recombinant collagen as the key bioactive ingredient. The Company also develops and manufactures rare ginsenosides technology-based functional foods. The Company mainly conducts its businesses within the domestic market.
Employees
1,512
More about the company
Date Price Change Volume
14/25/14 51.70 $ +6.05% 4,643,545
13/25/13 48.75 $ -1.42% 2,644,179
10/25/10 49.45 $ +6.69% 5,936,174
09/25/09 46.35 $ +0.22% 2,496,800
08/25/08 46.25 $ -0.96% 2,155,402

Delayed Quote Hong Kong S.E., January 14, 2025 at 01:38 pm IST

More quotes
Trading Rating
Investor Rating
ESG MSCI
BB
surperformance-ratings-light-chart GIANT-BIOGENE-HOLDING-CO-More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
21
Last Close Price
48.75HKD
Average target price
61.62HKD
Spread / Average Target
+26.40%
Consensus

Quarterly revenue - Rate of surprise